as on December 29, 2025 at 4:01 pm IST
Day's Low
9.50%
Downside
52 Week's Low
52 Week's High
80.97%
Downside
5.79%
Upside
as on December 29, 2025 at 4:01 pm IST
Market Cap
₹2,701.28 Cr
Return on Equity (ROE)
15.9
PE Ratio (TTM)
0Return on capital employed (ROCE)
21.76
Beta (LTM)
-0.46
P/B Ratio
15.17
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
340.74
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Shukra Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 2,701.28 | 5855.24% | 0.00 | 9 | 32 | |
| NA | 12.90 | -7.94% | 0.00 | NA | 51 | |
| NA | 12.70 | 3.02% | 0.00 | -3 | 28 | |
| NA | 869.67 | 123.92% | 0.51 | 18 | 156 | |
| NA | 19.60 | 40.1% | 0.00 | NA | 6 |
Get share price movements and forecasts by analysts on Shukra Pharma .
Source: S&P Global Market Intelligence
Investment in Shukra Pharmaceuticals Ltd Shares on INDmoney has grown by 98.23% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:98.23% versus previous 30 day period
Search interest for Shukra Pharmaceuticals Ltd Stock has increased by 87% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:87% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Shukra Pharma .
Shukra Pharmaceuticals Ltd’s net profit jumped 340.74% since last year same period to ₹2.38Cr in the Q2 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 131.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Shukra Pharmaceuticals Ltd has declared dividend of ₹0.01 per share on 04 Jun 2025 - translating a dividend yield of 0.02%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, Shukra Pharma. stock has moved up by 61.9%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 50.96% of holdings in Sep 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 48.93% of holdings in Sep 2025 quarter
| Organisation | Shukra Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| CEO | Dakshesh Shah |
| E-voting on shares | Click here to vote |
Shukra Pharma share price today stands at ₹61.69 as on . Shukra Pharma share today touched a day high of ₹61.69 and a low of ₹55.83.
Shukra Pharma touched a 52 week high of ₹65.26 and a 52 week low of ₹11.74. Shukra Pharma share price today i.e. is trending at ₹61.69, which is -5.47% down from its 52 week high and 425.47% up from its 52 week low.
Shukra Pharma market capitalisation is ₹2,701.28 Cr as on .
To buy Shukra Pharma shares, you need to follow these steps:
Shukra Pharma trading volume is 9.27L as on . This means that 9.27L shares of Shukra Pharma were bought and sold on the stock market during today's trading session.